Mycoplasma pneumoniae: Extrapulmonary Manifestations in Children With Focus on Mucocutaneous Disease

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review reveals that mycoplasma pneumoniae causes diverse extrapulmonary manifestations in children, highlighting mucocutaneous disease prevalence.

Extrapulmonary manifestations occur in approximately 25% of mycoplasma pneumoniae infections, with mucocutaneous disease being the most frequent.
The prospective myCAP study noted dermatological manifestations in 23% of children, demonstrating the impact of mycoplasma pneumoniae post-pandemic.
Diagnosis often relies on PCR for respiratory samples, establishing a definite connection between infection and extrapulmonary effects.
Immunomodulators like corticosteroids may effectively manage severe cases, pointing to the immune-mediated nature of these manifestations.

Sauteur et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Review reveals that mycoplasma pneumoniae causes diverse extrapulmonary manifestations in children, highlighting mucocutaneous disease prevalence.

Extrapulmonary manifestations occur in approximately 25% of mycoplasma pneumoniae infections, with mucocutaneous disease being the most frequent.
The prospective myCAP study noted dermatological manifestations in 23% of children, demonstrating the impact of mycoplasma pneumoniae post-pandemic.
Diagnosis often relies on PCR for respiratory samples, establishing a definite connection between infection and extrapulmonary effects.
Immunomodulators like corticosteroids may effectively manage severe cases, pointing to the immune-mediated nature of these manifestations.

Sauteur et al. (2025) studied this question.

Synapse has enriched one closely related paper. Consider it for comparative context:

View Full Paper

Ask AI

Bookmark